Family Office Of America (FOFA) Cash from Operations Growth (1y) (2022 - 2026)
Family Office Of America (FOFA) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | 347.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,066.05% |
| Dec 31, 2025 | -386.74% |
| Sep 30, 2025 | -5.35% |
| Jun 30, 2025 | -117.09% |
| Mar 31, 2025 | -97.00% |
| Dec 31, 2024 | -313.87% |
| Sep 30, 2024 | 27.98% |
| Jun 30, 2024 | -424.04% |
| Mar 31, 2024 | 77.94% |
| Dec 31, 2023 | 92.16% |
| Sep 30, 2023 | 84.91% |
| Jun 30, 2023 | 104.95% |
| Mar 31, 2023 | 58.59% |
| Dec 31, 2022 | 41.87% |
| Sep 30, 2022 | 56.89% |